Home - Atriva Therapeutics GmbH

First-in-class inhibitors against seasonal and pademic influenza

OVERVIEW

The site atriva-therapeutics.com presently has an average traffic classification of zero (the smaller the superior). We have downloaded zero pages within the web page atriva-therapeutics.com and found one website associating themselves with atriva-therapeutics.com.
Links to this site
1

ATRIVA-THERAPEUTICS.COM TRAFFIC

The site atriva-therapeutics.com is seeing fluctuating quantities of traffic through the year.
Traffic for atriva-therapeutics.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for atriva-therapeutics.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for atriva-therapeutics.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO ATRIVA-THERAPEUTICS.COM

WHAT DOES ATRIVA-THERAPEUTICS.COM LOOK LIKE?

Desktop Screenshot of atriva-therapeutics.com Mobile Screenshot of atriva-therapeutics.com Tablet Screenshot of atriva-therapeutics.com

ATRIVA-THERAPEUTICS.COM SERVER

We caught that a lone root page on atriva-therapeutics.com took one thousand two hundred and sixty-six milliseconds to download. I could not discover a SSL certificate, so in conclusion our crawlers consider this site not secure.
Load time
1.266 sec
SSL
NOT SECURE
IP
62.116.187.233

FAVICON

SERVER SOFTWARE

We discovered that atriva-therapeutics.com is employing the nginx os.

SITE TITLE

Home - Atriva Therapeutics GmbH

DESCRIPTION

First-in-class inhibitors against seasonal and pademic influenza

PARSED CONTENT

The site states the following, "First-in-class inhibitors against respiratory viral infections." I observed that the web page also stated " Invest in research to maximize profits! Projected retail peak sales of Atrivas MEK inhibitor ATR-002 in the indication Influenza in high-risk patients , as per-oral treatment regime over 5 days could be in excess of 600 Mio without considering pandemic events or additional indications." They also stated " Already in 2001 our scientists published a new antiviral mode of action. Learn more about the people from Atriva Therapeutics GmbH. Closed a seed financing o."

SEE MORE WEB PAGES

This Decay Records - Rock, Punk, Metal and Hardcore

Is a startup record label specialising in metal, punk and hardcore. Owned and run by Chris Nee and Dave Musson, This Decay is a label with a difference.

TriumphFX Analysis

2280 and the resistance level of 1.

Default Web Site Page

The IP address has changed. The IP address for this domain may have changed recently. Check your DNS settings to verify that the domain is set up correctly. It may take 8-24 hours for DNS changes to propagate. It may be possible to restore access to this site by following these instructions. For clearing your dns cache.